AR082711A1 - Concentrado para preparar una solucion medica que contiene carbonato de magnesio y/o cloruro de calcio anhidro - Google Patents
Concentrado para preparar una solucion medica que contiene carbonato de magnesio y/o cloruro de calcio anhidroInfo
- Publication number
- AR082711A1 AR082711A1 ARP110102984A ARP110102984A AR082711A1 AR 082711 A1 AR082711 A1 AR 082711A1 AR P110102984 A ARP110102984 A AR P110102984A AR P110102984 A ARP110102984 A AR P110102984A AR 082711 A1 AR082711 A1 AR 082711A1
- Authority
- AR
- Argentina
- Prior art keywords
- concentrate
- acid
- magnesium carbonate
- osmotic
- components
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Concentrado seco para preparar soluciones médicas, en especial soluciones de diálisis, que contienen componentes electrolíticos y amortiguadores y un osmótico, en donde el concentrado contiene carbonato de magnesio en lugar de cloruro de magnesio. El uso de carbonato de magnesio como electrolito evita la formación de “slurries”. Al usar glucosa anhidra como osmótico, y opcionalmente una separación espacial de este osmótico de otros componentes, se evita adicionalmente la presencia de “caking” en el concentrado. La presencia del “caking” se mejora también por el hecho de que el componente amortiguador hidrógeno-carbonato de sodio junto con cloruro de sodio se dispone aislado de todos los demás componentes. Este concentrado es adecuado en especial para usar en sistemas de bolsas de varias cámaras. El concentrado se caracteriza por una buena capacidad de disolución y una mejor estabilidad en almacenamiento.Reivindicación 1: Concentrado para preparar una solución médica, en donde el concentrado contiene a) carbonato de magnesio y/o b) cloruro de calcio anhidro. Reivindicación 3: Concentrado de acuerdo con la reivindicación 1 ó 2, en donde como carbonato de magnesio se usa 4MgCO3 x Mg(OH)2 x 5H2O. Reivindicación 5: Concentrado de acuerdo con una de las reivindicaciones 1 a 4, en donde el concentrado contiene un ácido de tolerancia fisiológica que está seleccionado preferentemente del grupo compuesto por ácido cítrico, ácido málico, ácido fumárico, ácido isocítrico, ácido succínico y ácido oxálico. Reivindicación 14: Concentrado de acuerdo con una de las reivindicaciones 1 a 13, en donde el concentrado está compuesto por al menos tres partes separadas espacialmente, en donde la primera parte contiene un concentrado de acuerdo con una de las reivindicaciones 1 - 5, la segunda parte contiene glucosa, y la tercera parte contiene hidrógeno-carbonato de sodio.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010039489A DE102010039489A1 (de) | 2010-08-18 | 2010-08-18 | Konzentrat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR082711A1 true AR082711A1 (es) | 2012-12-26 |
Family
ID=44651671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110102984A AR082711A1 (es) | 2010-08-18 | 2011-08-17 | Concentrado para preparar una solucion medica que contiene carbonato de magnesio y/o cloruro de calcio anhidro |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9249345B2 (es) |
| EP (1) | EP2605780B1 (es) |
| JP (1) | JP5807064B2 (es) |
| KR (1) | KR101771039B1 (es) |
| CN (2) | CN106038589A (es) |
| AR (1) | AR082711A1 (es) |
| AU (1) | AU2011290707B2 (es) |
| BR (1) | BR112013003723B1 (es) |
| CA (1) | CA2807753C (es) |
| DE (1) | DE102010039489A1 (es) |
| RU (1) | RU2613894C2 (es) |
| TW (1) | TWI551290B (es) |
| WO (1) | WO2012022775A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7736328B2 (en) | 2007-07-05 | 2010-06-15 | Baxter International Inc. | Dialysis system having supply container autoconnection |
| US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
| DE102011017048A1 (de) | 2011-04-14 | 2012-10-18 | Fresenius Medical Care Deutschland Gmbh | Mehrkammercontainer zur Herstellung medizinischer Lösungen |
| CN104586884A (zh) * | 2015-01-09 | 2015-05-06 | 李淑秀 | 新型血液透析浓缩液 |
| CA3022989A1 (en) | 2016-05-06 | 2017-11-09 | Gambro Lundia Ab | A disposable set for a peritoneal dialysis system |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2683664A (en) * | 1951-01-19 | 1954-07-13 | Alvis E Greer | Mineral concentrate |
| US3560380A (en) * | 1968-10-28 | 1971-02-02 | Mallinckrodt Chemical Works | Dry concentrates for preparing hemodialysis solutions |
| JPS56131515A (en) * | 1980-02-21 | 1981-10-15 | Veltman Preston Leonard | Dry composition for dialysis |
| US4756838A (en) * | 1980-02-21 | 1988-07-12 | Veltman Preston Leonard | Preparation of dry dialysate products |
| US4489535A (en) * | 1980-10-02 | 1984-12-25 | Veltman Preston Leonard | Materials and method for preparing dialysis solutions containing bicarbonate ions |
| US4396382A (en) * | 1981-12-07 | 1983-08-02 | Travenol European Research And Development Centre | Multiple chamber system for peritoneal dialysis |
| DD247844A1 (de) * | 1986-04-08 | 1987-07-22 | Berlin Chemie Veb | Verfahren zur herstellung eines lagerbestaendigen acetathaltigen elektrolyt-feststoffgemisches |
| DD247842A1 (de) * | 1986-04-08 | 1987-07-22 | Berlin Chemie Veb | Verfahren zur herstellung eines bicarbonathaltigen elektrolytmittels |
| DD247841A1 (de) * | 1986-04-08 | 1987-07-22 | Berlin Chemie Veb | Verfahren zur herstellung eines lagerungsstabilen elektrolytmittels |
| DE69030237T2 (de) | 1989-06-20 | 1997-07-31 | Otsuka Pharma Co Ltd | Kalispenderzubereitung |
| US5108767A (en) * | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
| JP2692580B2 (ja) | 1994-05-06 | 1997-12-17 | 株式会社ニッショー | 薬剤容器 |
| JP3589489B2 (ja) | 1994-09-12 | 2004-11-17 | サイテック株式会社 | 透析液の調剤に利用する薬剤と溶解調剤方法 |
| JPH08164198A (ja) | 1994-12-15 | 1996-06-25 | Cytec Kk | 固剤用容器が一体化の透析液調剤用固剤と溶解調剤装置 |
| AU1832197A (en) * | 1996-01-18 | 1997-08-11 | Fleming & Company, Pharmaceuticals | Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts |
| US6048553A (en) * | 1997-03-17 | 2000-04-11 | Macquarie Veterinary Supplies Pty Ltd | Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases |
| US6117100A (en) * | 1997-06-06 | 2000-09-12 | Powers; Kathleen M. | Hemodialysis-double dialyzers in parallel |
| JP3783752B2 (ja) * | 1997-10-02 | 2006-06-07 | 雪印乳業株式会社 | マグネシウム強化乳製品 |
| SE510587C2 (sv) * | 1997-10-07 | 1999-06-07 | Gambro Lundia Ab | Koncentrat för dialyslösning och användning därav |
| SE512349C2 (sv) * | 1997-11-28 | 2000-03-06 | Gambro Lundia Ab | Flerkammarbehållare för medicinsk lösning, förfarnde för beredning av medicinsk lösning för peritonealdialys samt användning av sådan behållare vid beredning av medicinsk lösning |
| US6605214B1 (en) * | 1999-03-03 | 2003-08-12 | Prismedical Corporation | Devices for preparing hemodialysis solutions |
| EP1059083B1 (en) | 1999-06-07 | 2004-04-14 | Nipro Corporation | A solid pharmaceutical preparation for dialysis and a process for producing the same |
| JP3714050B2 (ja) * | 1999-09-07 | 2005-11-09 | ニプロ株式会社 | 固形重曹透析用剤およびその製造方法 |
| US6309673B1 (en) * | 1999-09-10 | 2001-10-30 | Baxter International Inc. | Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy |
| JP4395995B2 (ja) * | 2000-05-31 | 2010-01-13 | 味の素株式会社 | 透析用製剤およびその製造方法 |
| JP2001340423A (ja) | 2000-05-31 | 2001-12-11 | Nikkiso Co Ltd | 透析用剤の容器 |
| JP2004515468A (ja) * | 2000-08-09 | 2004-05-27 | アルカベロ アクチェセルスカプ | 非経口ワクチン製剤およびその使用 |
| DK2116257T3 (da) * | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
| JP2002080048A (ja) | 2000-09-11 | 2002-03-19 | Fuso Pharmaceutical Industries Ltd | 複室包装袋およびその製造方法 |
| JP3899506B2 (ja) * | 2000-09-27 | 2007-03-28 | ニプロ株式会社 | 固形透析用製剤およびその製造方法 |
| JP2002102336A (ja) | 2000-09-27 | 2002-04-09 | Nipro Corp | 固形透析用製剤およびその製造方法 |
| DE10162959B4 (de) * | 2001-12-20 | 2017-10-12 | Fresenius Medical Care Deutschland Gmbh | Behälter enthaltend mindestens zwei Feststoffe und dessen Verwendung |
| US7122210B2 (en) | 2002-01-11 | 2006-10-17 | Baxter International Inc. | Bicarbonate-based solutions for dialysis therapies |
| CN1938058A (zh) * | 2004-03-30 | 2007-03-28 | 尼普洛株式会社 | 透析用固体制剂 |
| US20050276868A1 (en) * | 2004-06-10 | 2005-12-15 | Bart Degreve | Bicarbonate-based peritoneal dialysis solutions |
| EP1621177A1 (en) * | 2004-07-29 | 2006-02-01 | Fresenius Kabi Deutschland GmbH | Medical container with improved peelable seal |
| CN100360194C (zh) * | 2004-09-30 | 2008-01-09 | 广州明兴制药有限公司 | 一种无醋酸的碳酸氢盐血液透析剂 |
| DE102005001252A1 (de) * | 2005-01-11 | 2006-08-17 | Jobes Vital Gmbh | Zusammensetzung zur Behandlung der Apnoe, des Schnarchens und von Schlafstörungen |
| EP2035059B1 (en) | 2006-06-15 | 2015-11-18 | Metpro AB | Container, system and method for providing a solution |
| JP2008023958A (ja) | 2006-07-25 | 2008-02-07 | Higashi Nippon Power Fastening Kk | 切断機のワーク長さ測定装置 |
| JP5028122B2 (ja) | 2007-03-29 | 2012-09-19 | マナック株式会社 | 一剤型透析用固形剤およびその製造方法 |
| CN101366710A (zh) * | 2007-08-16 | 2009-02-18 | 北京信东联创生物技术有限公司 | 用于血液过滤术或血液透析术之医药组合物 |
| US9078808B2 (en) * | 2009-03-26 | 2015-07-14 | Warsaw Orthopedic, Inc. | Device to deliver magnesium in PEG formulation |
| DE102009058445B4 (de) * | 2009-12-16 | 2016-09-15 | Fresenius Medical Care Deutschland Gmbh | Mehrkammer-Beutel |
-
2010
- 2010-08-18 DE DE102010039489A patent/DE102010039489A1/de not_active Ceased
-
2011
- 2011-08-12 TW TW100128887A patent/TWI551290B/zh not_active IP Right Cessation
- 2011-08-17 US US13/814,900 patent/US9249345B2/en active Active
- 2011-08-17 WO PCT/EP2011/064180 patent/WO2012022775A1/de active Application Filing
- 2011-08-17 RU RU2013105217A patent/RU2613894C2/ru active
- 2011-08-17 AR ARP110102984A patent/AR082711A1/es not_active Application Discontinuation
- 2011-08-17 KR KR1020137006791A patent/KR101771039B1/ko active IP Right Grant
- 2011-08-17 AU AU2011290707A patent/AU2011290707B2/en not_active Ceased
- 2011-08-17 BR BR112013003723-7A patent/BR112013003723B1/pt active IP Right Grant
- 2011-08-17 CA CA2807753A patent/CA2807753C/en not_active Expired - Fee Related
- 2011-08-17 EP EP11752152.6A patent/EP2605780B1/de active Active
- 2011-08-17 CN CN201610657407.0A patent/CN106038589A/zh active Pending
- 2011-08-17 JP JP2013524451A patent/JP5807064B2/ja not_active Expired - Fee Related
- 2011-08-17 CN CN201180039534.XA patent/CN103068397B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20130134357A1 (en) | 2013-05-30 |
| US9249345B2 (en) | 2016-02-02 |
| KR20130098343A (ko) | 2013-09-04 |
| RU2613894C2 (ru) | 2017-03-21 |
| KR101771039B1 (ko) | 2017-08-24 |
| BR112013003723A2 (pt) | 2016-08-02 |
| JP2013535512A (ja) | 2013-09-12 |
| CA2807753C (en) | 2019-04-02 |
| CN103068397B (zh) | 2016-08-10 |
| BR112013003723B1 (pt) | 2019-07-09 |
| JP5807064B2 (ja) | 2015-11-10 |
| CN106038589A (zh) | 2016-10-26 |
| WO2012022775A1 (de) | 2012-02-23 |
| EP2605780B1 (de) | 2019-10-23 |
| TWI551290B (zh) | 2016-10-01 |
| AU2011290707A1 (en) | 2013-02-28 |
| CA2807753A1 (en) | 2012-02-23 |
| DE102010039489A1 (de) | 2012-02-23 |
| CN103068397A (zh) | 2013-04-24 |
| RU2013105217A (ru) | 2014-09-27 |
| TW201219042A (en) | 2012-05-16 |
| EP2605780A1 (de) | 2013-06-26 |
| AU2011290707B2 (en) | 2015-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR082711A1 (es) | Concentrado para preparar una solucion medica que contiene carbonato de magnesio y/o cloruro de calcio anhidro | |
| AR049298A1 (es) | Soluciones para dialisis peritoneal a base de bicarbonato,metodo de preparacion y recipiente de multiples camaras | |
| PE20121517A1 (es) | Compuestos lipopeptidos y metodos relacionados | |
| JP2014518844A5 (es) | ||
| RU2015122023A (ru) | Стабилизированная композиция пеметрекседа | |
| AR095964A1 (es) | Formulaciones para la preservación de órganos y tejidos con mayor estabilidad y vida útil | |
| CR10992A (es) | Preparacion solida que comprende alogliptina y pioglitazona | |
| NZ743984A (en) | Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions | |
| WO2011161056A3 (en) | Dialysis precursor composition | |
| JP2011500711A5 (es) | ||
| JP2015527385A5 (es) | ||
| AR081579A1 (es) | Mezclas electroliticas que proveen un sabor salado reducido | |
| PH12016500909B1 (en) | Solutons for increasing the stability and shelf life of an organ tissue preservation solution | |
| AR088918A1 (es) | Composiciones antitranspirantes anhidras | |
| HRP20211761T1 (hr) | Dvokomponentna kompozicija koja sadrži acetilsalicilnu kiselinu | |
| CL2015000957A1 (es) | Métodos para reducir la formación de encrustante | |
| AR087371A1 (es) | Formulaciones de (trimetoxifenilamino)pirimidinilo, metodos | |
| AR107297A1 (es) | MÉTODO PARA LA PURIFICACIÓN DE ²²⁷Th | |
| CN103830271A (zh) | 一种消毒液组合物及其用途 | |
| PE20142064A1 (es) | Estabilizacion de una disolucion acuosa de una sal de hierro organico | |
| US10835660B2 (en) | Dialysis solution | |
| RU2013115268A (ru) | Кислотный диализный концентрат | |
| AR084299A1 (es) | Composicion farmaceutica para una administracion por via oral destinada a evitar el mal uso | |
| CA2903759C (en) | Concentrated aqueous azalide formulations | |
| RU2009131757A (ru) | Оксалиплатиновая фармацевтическая композиция с буфером на основе сахарного спирта |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |